Your browser doesn't support javascript.
loading
Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple Myeloma.
Yan, Xiaoyu; Clemens, Pamela L; Puchalski, Thomas; Lonial, Sagar; Lokhorst, Henk; Voorhees, Peter M; Usmani, Saad; Richardson, Paul G; Plesner, Torben; Liu, Kevin; Orlowski, Robert Z; Losic, Nedjad; Jansson, Richard; Ahmadi, Tahamtan; Lantz, Kristen; Ruixo, Juan Jose Perez; Zhou, Honghui; Xu, Xu Steven.
Affiliation
  • Yan X; Janssen Research & Development, LLC, Raritan, NJ, USA.
  • Clemens PL; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Puchalski T; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Lonial S; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Lokhorst H; VU University Medical Center, Amsterdam, The Netherlands.
  • Voorhees PM; Levine Cancer Institute/Carolinas HealthCare System, Charlotte, NC, USA.
  • Usmani S; Levine Cancer Institute/Carolinas HealthCare System, Charlotte, NC, USA.
  • Richardson PG; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Plesner T; Vejle Hospital and University of Southern Denmark, Vejle, Denmark.
  • Liu K; Janssen Research & Development, LLC, Raritan, NJ, USA.
  • Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Losic N; Genmab A/S, Copenhagen, Denmark.
  • Jansson R; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Ahmadi T; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Lantz K; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Ruixo JJP; Janssen Research & Development, Beerse, Belgium.
  • Zhou H; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Xu XS; Janssen Research & Development, LLC, Raritan, NJ, USA. sxu26@its.jnj.com.
Clin Pharmacokinet ; 57(4): 529-538, 2018 04.
Article in En | MEDLINE | ID: mdl-28983805

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Antibodies, Monoclonal / Multiple Myeloma Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Pharmacokinet Year: 2018 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Antibodies, Monoclonal / Multiple Myeloma Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Pharmacokinet Year: 2018 Type: Article Affiliation country: United States